Swixx Biopharma acquires Biopas to expand in Latin America
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
The combined entity will enable us to better serve the needs of patients, healthcare professionals and our customers around the world
Establishing Asymchem’s first manufacturing footprint in Europe
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Launch of 20 new medicines expected by 2030
Additional data from APPRAISE ATP trial reinforce modular therapy approach
ASG Group of Eye Hospitals has 165+ branches in 85+ cities across India and abroad
Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for COPD
The award recognizes powerful science–industry collaborations for social good
Subscribe To Our Newsletter & Stay Updated